Modafinil reinstates a cocaine conditioned place preference following extinction in rats

Behavioural Brain Research

Volumn 204, Issue 1, 2009, Pages 250-253

  Bernardi, Rick E ^a   Lewis, Jason R ^b   Lattal, K Matthew ^a   Berger, S Paul ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Cocaine; Conditioned place preference; Modafinil; Reinstatement

Indexed keywords

COCAINE; MODAFINIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ENVIRONMENTAL FACTOR; MALE; MENTAL TEST; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RELAPSE; SOCIAL BEHAVIOR; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; ANIMALS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CONDITIONING, CLASSICAL; DOPAMINE UPTAKE INHIBITORS; ENVIRONMENT; EXTINCTION, PSYCHOLOGICAL; MALE; MOTOR ACTIVITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SPACE PERCEPTION; TIME FACTORS;

EID: 67849130401     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.05.028     Document Type: Article

References (27)

1. Anderson S.M., and Pierce R.C. Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol Ther 106 (2005) 389-403
2. Berger S.P., Hall S., Mickalian J.D., Reid M.S., Crawford C.A., Delucchi K., et al. Haloperidol antagonism of cue-elicited cocaine craving. Lancet 347 (1996) 504-508
3. Bormann N.M., and Cunningham C.L. The effects of naloxone on expression and acquisition of ethanol place conditioning in rats. Pharmacol Biochem Behav 58 (1997) 975-982
4. Cunningham C.L., Gremel C.M., and Groblewski P.A. Drug-induced conditioned place preference and aversion in mice. Nat Protoc 1 (2006) 1662-1670
5. Deroche-Gamonet V., Darnaudery M., Bruins-Slot L., Piat F., Le Moal M., and Piazza P.V. Study of the addictive potential of modafinil in naive and cocaine-experienced rats. Psychopharmacology (Berl) 161 (2002) 387-395
6. Dopheide M.M., Morgan R.E., Rodvelt K.R., Schachtman T.R., and Miller D.K. Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants. Eur J Pharmacol 568 (2007) 112-123
7. Duteil J., Rambert F.A., Pessonnier J., Hermant J.F., Gombert R., and Assous E. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol 180 (1990) 49-58
8. Ferraro L., Tanganelli S., O'Connor W.T., Antonelli T., Rambert F., and Fuxe K. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol 306 (1996) 33-39
9. Gold L.H., and Balster R.L. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology (Berl) 126 (1996) 286-292
10. Graham D.L., Hoppenot R., Hendryx A., and Self D.W. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats. Psychopharmacology (Berl) 191 (2007) 719-730
11. Gremel C.M., and Cunningham C.L. Role of test activity in ethanol-induced disruption of place preference expression in mice. Psychopharmacology (Berl) 191 (2007) 195-202
12. Hart C.L., Haney M., Vosburg S.K., Rubin E., and Foltin R.W. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33 (2008) 761-768
13. Itzhak Y. Blockade of sensitization to the toxic effects of cocaine in mice by nitric oxide synthase inhibitors. Pharmacol Toxicol 74 (1994) 162-166
14. Itzhak Y., and Martin J.L. Cocaine-induced conditioned place preference in mice: induction, extinction and reinstatement by related psychostimulants. Neuropsychopharmacology 26 (2002) 130-134
15. Madras B.K., Xie Z., Lin Z., Jassen A., Panas H., Lynch L., et al. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 319 (2006) 561-569
16. Mignot E., Nishino S., Guilleminault C., and Dement W.C. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17 (1994) 436-437
17. Minzenberg M.J., and Carter C.S. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33 (2008) 1477-1502
18. Mitchell H.A., Bogenpohl J.W., Liles L.C., Epstein M.P., Bozyczko-Coyne D., Williams M., et al. Behavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action. Pharmacol Biochem Behav 91 (2008) 217-222
19. Mueller D., and Stewart J. Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav Brain Res 115 (2000) 39-47
20. Murillo-Rodriguez E., Haro R., Palomero-Rivero M., Millan-Aldaco D., and Drucker-Colin R. Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats. Behav Brain Res 176 (2007) 353-357
21. Rambert F.A., Pessonnier J., Duteil J., and Modafinil-. amphetamine- and methylphenidate-induced hyperactivities in mice involve different mechanisms. Eur J Pharmacol 183 (1990) 455-456
22. Ritz M.C., Lamb R.J., Goldberg S.R., and Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 (1987) 1219-1223
23. Rush C.R., Kelly T.H., Hays L.R., and Wooten A.F. Discriminative-stimulus effects of modafinil in cocaine-trained humans. Drug Alcohol Depend 67 (2002) 311-322
24. Schweri M.M., Skolnick P., Rafferty M.F., Rice K.C., Janowsky A.J., and Paul S.M. [3H]Threo-(+/-)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. J Neurochem 45 (1985) 1062-1070
25. Stathis M., Scheffel U., Lever S.Z., Boja J.W., Carroll F.I., and Kuhar M.J. Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology (Berl) 119 (1995) 376-384
26. Volkow N.D., Fowler J.S., Logan J., Alexoff D., Zhu W., Telang F., et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 301 (2009) 1148-1154
27. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., and Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 21 (2001) 1787-1794